HealthDay - THURSDAY, Aug. 10 (HealthDay News) -- Researchers are describing what seems to be a real-life medical nightmare: A cancer that spreads from animal to animal like an infection.

HealthDay - THURSDAY, Aug. 10 (HealthDay News) -- Researchers are describing what seems to be a real-life medical nightmare: A cancer that spreads from animal to animal like an infection.

SPACE.com / LiveScience.com - Dogs have a form of sexually transmitted cancer that for 200 to 2,500 years has apparently spread via contagious tumor cells that escaped from their original body and now travel around the world as parasites.

According to a press release from the National Cancer Institute (NCI), although most Americans are familiar with common cancer screenings, the majority of citizens do not know when or how often these tests should be made. The recommendations of appropriate testing according to age and...

HealthDay - WEDNESDAY, Aug. 9 (HealthDay News) -- An experimental gene-based drug is able to "trick" its way into prostate cancer cells and kill them, U.S. researchers report.

AP - Scientists have created a gene profiling test that may someday help reveal which people with early lung cancer are likely to suffer a relapse and would benefit most from chemotherapy.

Researchers claim to have made a test that could most likely determine if a common form of lung cancer will reappear after surgery. With that knowledge, a doctor can adjust treatment accordingly by administering stronger drugs....

HealthDay - WEDNESDAY, Aug. 9 (HealthDay News) -- An experimental gene-based drug is able to "trick" its way into prostate cancer cells and kill them, U.S. researchers report.

AP - Scientists have created a gene profiling test that may someday help reveal which people with early lung cancer are likely to suffer a relapse and would benefit most from chemotherapy.

Reuters - Researchers say they have developed a test that can predict with near certainty whether the most common form of lung cancer will return after surgery.

Reuters - African-American men with early nonpalpable prostate cancer have greater tumor volume than white men with similar prostate specific antigen (PSA) levels, a study shows. This suggests that the threshold for PSA should be lowered in black men.

Thousands of women whose mothers took an anti-miscarriage drug are twice as likely to develop breast cancer, says researchers in the journal Cancer Epidemiology, Biomarkers and Prevention. DES, a synthetic estrogen - diethylstilbestrol - is commonly prescribed to pregnant women between the 40s...

HealthDay - TUESDAY, Aug. 8 (HealthDay News) -- Women whose mothers took DES, a synthetic estrogen, while pregnant have nearly double the risk of breast cancer.

A research by scientists at Boston University's School of Public Health has revealed that the daughters of the thousands of women who took an anti-miscarriage pill more than 40 years ago have double the risk of getting breast cancer. The research has been published in the journal Cancer...

Reuters - Many prostate cancer survivors who have sexual difficulties post-treatment have never tried erectile dysfunction therapies, such as Viagra, a new study shows.

HealthDay - TUESDAY, Aug. 8 (HealthDay News) -- Women whose mothers took DES, a synthetic estrogen, while pregnant have nearly double the risk of breast cancer.

A U.S. study says that women who took an anti-miscarriage drug during pregnancy doubled the risk of breast cancer for their daughters. An estimated 300,000 UK women starting the 1940s to the early 1970s took the drug Diethylstilbestrol (DES)....

American Cancer Society - Summary: Women whose mothers took the drug DES during pregnancy may have a higher risk for breast cancer than women not exposed to the drug in utero. The new finding suggests these women should be especially vigilant about breast cancer screening, researchers at Boston University School of Public Health say. Their work appears in the journal Cancer Epidemiology, Biomarkers, and Prevention.

Research by an international team of scientists suggests that the burden of cancer is radically related to heavy alcohol consumption. In a recent issue of the International Journal of Cancer, researchers report that 3.6 percent of all cancer cases worldwide are related to alcohol drinking, and...

One of the six men who became violently ill in March during clinical trials of a new drug has been told by his doctors that he is showing "definite early signs" of lymph cancer. David Oakley, 35, was one of six men who became violently ill during the trial and had to be rushed to the hospital....